🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to study the effects of aging and estrogen on ...
Status
Unknown
Location
Massachusetts General Hospital
Start Date
2002-01
Trial ID
NCT00386022
Treatments Being Tested
This trial is conducted in Europe. The aim of this trial is to to evaluate ...
Status
Completed
Location
Novo Nordisk Investigational Site
Start Date
2007-01
Trial ID
NCT01486979
Treatments Being Tested
This is a 4-arm study to evaluate and compare bleeding patterns between thr...
Status
Completed
Location
Duramed Investigational Site
Start Date
2006-10
Trial ID
NCT00394771
Treatments Being Tested
The aim of this study is to investigate whether 1000 micrograms of self-adm...
Status
Completed
Location
Gynaecological Department, Ullevål University Hospital
Start Date
2008-01
Trial ID
NCT00572819
Treatments Being Tested
Sponsor has decided to discontinue Luveris® in the United States (US) due t...
Status
Terminated
Location
U.S. Medical Information, 1-888-275-7376
Start Date
2006-03
Trial ID
NCT00328926
The purpose of the study is to determine the bioequivalence of Norgestimate...
Status
Completed
Location
Multiple Locations
Start Date
2005-04
Trial ID
NCT00709644
Treatments Being Tested
This trial is conducted in Europe. The aim of this trial is to compare the ...
Status
Completed
Location
Multiple Locations
Start Date
2010-03
Trial ID
NCT01085877
Treatments Being Tested
This study is conducted in Europe. The aim of this study is to investigate ...
Status
Completed
Location
Novo Nordisk Investigational Site
Start Date
2006-04
Trial ID
NCT01507454
Treatments Being Tested
The purpose of the blood spot validation portion of the study is to test if...
Status
Completed
Location
Oregon Health & Science University
Start Date
2006-01
Trial ID
NCT00662454
Treatments Being Tested
Ultra-low-dose oral E2/D will have more beneficial effects than trans-derma...
Status
Unknown
Location
Chelsea and Westminster NHS Foundation Trust
Start Date
2013-11
Trial ID
NCT02264743
Treatments Being Tested